Consun Pharmaceutical Group Limited (HKG: 1681)
Hong Kong
· Delayed Price · Currency is HKD 8.45
-0.03 (-0.35%)
Nov 21, 2024, 4:08 PM HKT
Consun Pharmaceutical Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 7,012 | 3,780 | 3,193 | 3,495 | 2,439 | 3,924 | Upgrade
|
| Market Cap Growth | 9.45% | 18.38% | -8.64% | 43.27% | -37.84% | 0.83% | Upgrade
|
| Enterprise Value | 4,029 | 1,258 | 1,225 | 2,132 | 1,743 | 3,518 | Upgrade
|
| Last Close Price | 8.45 | 4.10 | 3.18 | 3.28 | 2.14 | 3.09 | Upgrade
|
| PE Ratio | 7.59 | 4.37 | 4.14 | 4.82 | 4.12 | 43.95 | Upgrade
|
| Forward PE | 7.08 | 3.80 | 3.80 | 3.80 | 3.76 | 6.33 | Upgrade
|
| PS Ratio | 2.29 | 1.32 | 1.21 | 1.39 | 1.17 | 2.03 | Upgrade
|
| PB Ratio | 1.75 | 0.88 | 0.82 | 0.98 | 0.82 | 1.52 | Upgrade
|
| P/TBV Ratio | 1.25 | 1.03 | 1.00 | 1.25 | 1.11 | 2.20 | Upgrade
|
| P/FCF Ratio | 7.84 | 4.48 | 3.15 | 4.54 | 2.51 | 17.23 | Upgrade
|
| P/OCF Ratio | 4.67 | 4.19 | 2.98 | 3.92 | 2.37 | 9.15 | Upgrade
|
| PEG Ratio | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | Upgrade
|
| EV/Sales Ratio | 1.37 | 0.44 | 0.46 | 0.85 | 0.84 | 1.82 | Upgrade
|
| EV/EBITDA Ratio | 3.90 | 1.27 | 1.38 | 2.38 | 2.37 | 5.55 | Upgrade
|
| EV/EBIT Ratio | 4.25 | 1.38 | 1.51 | 2.63 | 2.67 | 6.34 | Upgrade
|
| EV/FCF Ratio | 4.50 | 1.49 | 1.21 | 2.77 | 1.79 | 15.45 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.13 | 0.21 | 0.22 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 0.54 | 0.57 | 0.58 | 0.83 | 0.88 | 0.97 | Upgrade
|
| Debt / FCF Ratio | 0.62 | 0.67 | 0.51 | 0.97 | 0.67 | 2.72 | Upgrade
|
| Asset Turnover | 0.52 | 0.50 | 0.51 | 0.49 | 0.46 | 0.45 | Upgrade
|
| Inventory Turnover | 2.00 | 1.99 | 2.12 | 2.13 | 1.97 | 2.22 | Upgrade
|
| Quick Ratio | 2.78 | 2.60 | 2.47 | 2.06 | 1.80 | 1.68 | Upgrade
|
| Current Ratio | 3.06 | 2.86 | 2.68 | 2.25 | 2.00 | 1.86 | Upgrade
|
| Return on Equity (ROE) | 22.16% | 21.38% | 21.53% | 21.64% | 19.98% | 2.63% | Upgrade
|
| Return on Assets (ROA) | 10.49% | 9.93% | 9.66% | 9.93% | 8.98% | 8.16% | Upgrade
|
| Return on Capital (ROIC) | 12.79% | 12.39% | 12.05% | 12.53% | 11.60% | 10.79% | Upgrade
|
| Earnings Yield | 19.57% | 22.87% | 24.18% | 20.73% | 24.28% | 2.28% | Upgrade
|
| FCF Yield | 19.48% | 22.34% | 31.73% | 22.03% | 39.84% | 5.80% | Upgrade
|
| Dividend Yield | 7.08% | 10.98% | 9.44% | 9.14% | 13.08% | 6.48% | Upgrade
|
| Payout Ratio | 67.96% | 41.59% | 18.67% | 33.56% | 26.36% | 282.57% | Upgrade
|
| Buyback Yield / Dilution | -1.69% | -0.91% | 1.58% | 1.54% | 4.35% | 2.68% | Upgrade
|
| Total Shareholder Return | 5.39% | 10.08% | 11.02% | 10.67% | 17.43% | 9.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.